List of Excipients in API rifamycin
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing rifamycin
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| RedHill Biopharma Ltd | AEMCOLO | rifamycin | 57841-1200 | AMMONIO METHACRYLATE COPOLYMER TYPE B | 2028-11-16 |
| RedHill Biopharma Ltd | AEMCOLO | rifamycin | 57841-1200 | ASCORBIC ACID | 2028-11-16 |
| RedHill Biopharma Ltd | AEMCOLO | rifamycin | 57841-1200 | FERRIC OXIDE YELLOW | 2028-11-16 |
| RedHill Biopharma Ltd | AEMCOLO | rifamycin | 57841-1200 | GLYCERYL DISTEARATE | 2028-11-16 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for rifamycin
Excipient focus: AMMONIO METHACRYLATE COPOLYMER TYPE B
rifamycin drug variants containing AMMONIO METHACRYLATE COPOLYMER TYPE B
| Company | Ingredient | NDC |
|---|---|---|
| RedHill Biopharma Ltd | rifamycin | 57841-1200 |
| Aries Pharmaceuticals Inc | rifamycin | 71068-001 |
| >Company | >Ingredient | >NDC |
rifamycin drug variants not containing AMMONIO METHACRYLATE COPOLYMER TYPE B
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ASCORBIC ACID
rifamycin drug variants containing ASCORBIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| RedHill Biopharma Ltd | rifamycin | 57841-1200 |
| Aries Pharmaceuticals Inc | rifamycin | 71068-001 |
| >Company | >Ingredient | >NDC |
rifamycin drug variants not containing ASCORBIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
rifamycin drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| RedHill Biopharma Ltd | rifamycin | 57841-1200 |
| Aries Pharmaceuticals Inc | rifamycin | 71068-001 |
| >Company | >Ingredient | >NDC |
rifamycin drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL DISTEARATE
rifamycin drug variants containing GLYCERYL DISTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| RedHill Biopharma Ltd | rifamycin | 57841-1200 |
| Aries Pharmaceuticals Inc | rifamycin | 71068-001 |
| >Company | >Ingredient | >NDC |
rifamycin drug variants not containing GLYCERYL DISTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LECITHIN, SOYBEAN
rifamycin drug variants containing LECITHIN, SOYBEAN
| Company | Ingredient | NDC |
|---|---|---|
| RedHill Biopharma Ltd | rifamycin | 57841-1200 |
| Aries Pharmaceuticals Inc | rifamycin | 71068-001 |
| >Company | >Ingredient | >NDC |
rifamycin drug variants not containing LECITHIN, SOYBEAN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
rifamycin drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| RedHill Biopharma Ltd | rifamycin | 57841-1200 |
| Aries Pharmaceuticals Inc | rifamycin | 71068-001 |
| >Company | >Ingredient | >NDC |
rifamycin drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
rifamycin drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| RedHill Biopharma Ltd | rifamycin | 57841-1200 |
| Aries Pharmaceuticals Inc | rifamycin | 71068-001 |
| >Company | >Ingredient | >NDC |
rifamycin drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
rifamycin drug variants containing METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| RedHill Biopharma Ltd | rifamycin | 57841-1200 |
| Aries Pharmaceuticals Inc | rifamycin | 71068-001 |
| >Company | >Ingredient | >NDC |
rifamycin drug variants not containing METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 6000
rifamycin drug variants containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| RedHill Biopharma Ltd | rifamycin | 57841-1200 |
| Aries Pharmaceuticals Inc | rifamycin | 71068-001 |
| >Company | >Ingredient | >NDC |
rifamycin drug variants not containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
rifamycin drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| RedHill Biopharma Ltd | rifamycin | 57841-1200 |
| Aries Pharmaceuticals Inc | rifamycin | 71068-001 |
| >Company | >Ingredient | >NDC |
rifamycin drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
rifamycin drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| RedHill Biopharma Ltd | rifamycin | 57841-1200 |
| Aries Pharmaceuticals Inc | rifamycin | 71068-001 |
| >Company | >Ingredient | >NDC |
rifamycin drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
rifamycin drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| RedHill Biopharma Ltd | rifamycin | 57841-1200 |
| Aries Pharmaceuticals Inc | rifamycin | 71068-001 |
| >Company | >Ingredient | >NDC |
rifamycin drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIETHYL CITRATE
rifamycin drug variants containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| RedHill Biopharma Ltd | rifamycin | 57841-1200 |
| Aries Pharmaceuticals Inc | rifamycin | 71068-001 |
| >Company | >Ingredient | >NDC |
rifamycin drug variants not containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch